• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Alternative splicing and cell survival: from tissue homeostasis to disease.可变剪接与细胞存活:从组织稳态到疾病
Cell Death Differ. 2016 Dec;23(12):1919-1929. doi: 10.1038/cdd.2016.91. Epub 2016 Sep 30.
2
Prp40 pre-mRNA processing factor 40 homolog B (PRPF40B) associates with SF1 and U2AF65 and modulates alternative pre-mRNA splicing in vivo.Prp40前体mRNA加工因子40同源物B(PRPF40B)与SF1和U2AF65结合,并在体内调节前体mRNA的可变剪接。
RNA. 2015 Mar;21(3):438-57. doi: 10.1261/rna.047258.114. Epub 2015 Jan 20.
3
Hypoxia alters splicing of the cancer associated Fas gene.缺氧改变了与癌症相关的 Fas 基因的剪接。
Exp Cell Res. 2019 Jul 1;380(1):29-35. doi: 10.1016/j.yexcr.2019.04.015. Epub 2019 Apr 17.
4
Alternative RNA splicing in tumour heterogeneity, plasticity and therapy.肿瘤异质性、可塑性和治疗中的可变剪接。
Dis Model Mech. 2022 Jan 1;15(1). doi: 10.1242/dmm.049233. Epub 2022 Jan 11.
5
Unbalanced alternative splicing and its significance in cancer.不平衡的可变剪接及其在癌症中的意义。
Bioessays. 2006 Apr;28(4):378-86. doi: 10.1002/bies.20390.
6
Differential Impacts of Alternative Splicing Networks on Apoptosis.可变剪接网络对细胞凋亡的不同影响。
Int J Mol Sci. 2016 Dec 14;17(12):2097. doi: 10.3390/ijms17122097.
7
Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.SR 和 hnRNP 家族的剪接因子作为癌症细胞凋亡的调节剂。
Cancer Lett. 2017 Jun 28;396:53-65. doi: 10.1016/j.canlet.2017.03.013. Epub 2017 Mar 14.
8
Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.癌症相关的前体信使核糖核酸可变剪接扰动
Cancer Treat Res. 2013;158:41-94. doi: 10.1007/978-3-642-31659-3_3.
9
MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing.MutPred剪接:基于机器学习预测破坏剪接的外显子变体。
Genome Biol. 2014 Jan 13;15(1):R19. doi: 10.1186/gb-2014-15-1-r19.
10
[Perspectives of RNA interference application in the therapy of diseases associated with defects in alternative RNA splicing].[RNA干扰在与可变RNA剪接缺陷相关疾病治疗中的应用前景]
Postepy Hig Med Dosw (Online). 2012 Sep 18;66:683-95. doi: 10.5604/17322693.1010502.

引用本文的文献

1
Alternative splicing factor RAB3IP as a novel risk signature to predict the prognosis of colorectal cancer.可变剪接因子RAB3IP作为预测结直肠癌预后的新型风险标志物。
J Cancer. 2025 Jun 23;16(9):2959-2969. doi: 10.7150/jca.110271. eCollection 2025.
2
Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets.颅咽管瘤中剪接机制受损揭示PRPF8和RAVER1作为新型生物标志物和治疗靶点。
Acta Neuropathol Commun. 2025 Jun 28;13(1):142. doi: 10.1186/s40478-025-02040-w.
3
Oncogenic Fusions Harboring Genes: Exploring Novel Targetable Opportunities in Prostate Cancer.携带基因的致癌融合:探索前列腺癌新的可靶向治疗机会
Cancers (Basel). 2025 May 14;17(10):1657. doi: 10.3390/cancers17101657.
4
Unravelling Convergent Signaling Mechanisms Underlying the Aging-Disease Nexus Using Computational Language Analysis.使用计算语言分析揭示衰老与疾病关联背后的趋同信号机制。
Curr Issues Mol Biol. 2025 Mar 14;47(3):189. doi: 10.3390/cimb47030189.
5
The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomes.血液基因表达和剪接的遗传决定因素对分子表型和健康结果的贡献。
Nat Genet. 2025 Mar;57(3):616-625. doi: 10.1038/s41588-025-02096-3. Epub 2025 Mar 4.
6
Caspase-8: Arbitrating Life and Death in the Innate Immune System.半胱天冬酶-8:在固有免疫系统中决定生死
Cells. 2025 Feb 7;14(4):240. doi: 10.3390/cells14040240.
7
DHX9 helicase impacts on splicing decisions by modulating U2 snRNP recruitment in Ewing sarcoma cells.DHX9解旋酶通过调节尤因肉瘤细胞中U2小核核糖核蛋白的募集来影响剪接决定。
Nucleic Acids Res. 2025 Feb 8;53(4). doi: 10.1093/nar/gkaf068.
8
Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53.孤儿核受体NR2E3通过激活p53成为实体瘤中的一种新的分子易损靶点。
Cell Death Dis. 2025 Jan 14;16(1):15. doi: 10.1038/s41419-025-07337-1.
9
Tipping the balance of cell death: alternative splicing as a source of MCL-1S in cancer.颠覆细胞死亡的平衡:可变剪接作为癌症中MCL-1S的一个来源
Cell Death Dis. 2024 Dec 18;15(12):917. doi: 10.1038/s41419-024-07307-z.
10
Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer.PBRM1 的可变剪接介导了肾癌对 PD-1 阻断治疗的耐药性。
EMBO J. 2024 Nov;43(22):5421-5444. doi: 10.1038/s44318-024-00262-7. Epub 2024 Oct 7.

本文引用的文献

1
U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation.U2AF35(S34F)通过引导异常的自噬相关蛋白7(ATG7)前体信使核糖核酸(pre-mRNA)3'末端形成促进细胞转化。
Mol Cell. 2016 May 19;62(4):479-90. doi: 10.1016/j.molcel.2016.04.011. Epub 2016 May 12.
2
p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration.p53 异构体调节星形胶质细胞介导的神经保护和神经退行性变。
Cell Death Differ. 2016 Sep 1;23(9):1515-28. doi: 10.1038/cdd.2016.37. Epub 2016 Apr 22.
3
BECN1s, a short splice variant of BECN1, functions in mitophagy.BECN1s是BECN1的一种短剪接变体,在线粒体自噬中发挥作用。
Autophagy. 2015 Nov 2;11(11):2048-2056. doi: 10.1080/15548627.2015.1100785.
4
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.反义寡核苷酸介导的MDM4外显子6跳跃抑制肿瘤生长。
J Clin Invest. 2016 Jan;126(1):68-84. doi: 10.1172/JCI82534. Epub 2015 Nov 23.
5
The RNA Splicing Response to DNA Damage.RNA剪接对DNA损伤的反应。
Biomolecules. 2015 Oct 29;5(4):2935-77. doi: 10.3390/biom5042935.
6
Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.基因毒性应激通过调节RNA解旋酶DHX9的可变前体mRNA加工来抑制尤因肉瘤细胞的生长。
Oncotarget. 2015 Oct 13;6(31):31740-57. doi: 10.18632/oncotarget.5033.
7
The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7.RNA结合蛋白Sam68调节雄激素受体剪接变体AR-V7的表达和转录功能。
Sci Rep. 2015 Aug 27;5:13426. doi: 10.1038/srep13426.
8
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.癌症中的异常RNA剪接;剪接因子基因的表达变化和驱动突变
Oncogene. 2016 May 12;35(19):2413-27. doi: 10.1038/onc.2015.318. Epub 2015 Aug 24.
9
Splicing Regulation: A Molecular Device to Enhance Cancer Cell Adaptation.剪接调控:一种增强癌细胞适应性的分子机制
Biomed Res Int. 2015;2015:543067. doi: 10.1155/2015/543067. Epub 2015 Jul 26.
10
SAM68: Signal Transduction and RNA Metabolism in Human Cancer.SAM68:人类癌症中的信号转导与RNA代谢
Biomed Res Int. 2015;2015:528954. doi: 10.1155/2015/528954. Epub 2015 Jul 26.

可变剪接与细胞存活:从组织稳态到疾病

Alternative splicing and cell survival: from tissue homeostasis to disease.

作者信息

Paronetto Maria Paola, Passacantilli Ilaria, Sette Claudio

机构信息

Department of Movement, Human and Health Sciences, University of Rome 'Foro Italico', Rome 00135, Italy.

Laboratories of Cellular and Molecular Neurobiology and of Neuroembryology, Fondazione Santa Lucia, Rome 00143, Italy.

出版信息

Cell Death Differ. 2016 Dec;23(12):1919-1929. doi: 10.1038/cdd.2016.91. Epub 2016 Sep 30.

DOI:10.1038/cdd.2016.91
PMID:27689872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5136496/
Abstract

Most human genes encode multiple mRNA variants and protein products through alternative splicing of exons and introns during pre-mRNA processing. In this way, alternative splicing amplifies enormously the coding potential of the human genome and represents a powerful evolutionary resource. Nonetheless, the plasticity of its regulation is prone to errors and defective splicing underlies a large number of inherited and sporadic diseases, including cancer. One key cellular process affected by alternative splicing is the programmed cell death or apoptosis. Many apoptotic genes encode for splice variants having opposite roles in cell survival. This regulation modulates cell and tissue homeostasis and is implicated in both developmental and pathological processes. Furthermore, recent evidence has also unveiled splicing-mediated regulation of genes involved in autophagy, another essential process for tissue homeostasis. In this review, we highlight some of the best-known examples of alternative splicing events involved in cell survival. Emphasis is given to the role of this regulation in human cancer and in the response to chemotherapy, providing examples of how alternative splicing of apoptotic genes can be exploited therapeutically.

摘要

大多数人类基因通过前体mRNA加工过程中外显子和内含子的可变剪接来编码多种mRNA变体和蛋白质产物。通过这种方式,可变剪接极大地扩展了人类基因组的编码潜力,并代表了一种强大的进化资源。尽管如此,其调控的可塑性容易出错,剪接缺陷是包括癌症在内的大量遗传性和散发性疾病的基础。可变剪接影响的一个关键细胞过程是程序性细胞死亡或凋亡。许多凋亡基因编码在细胞存活中具有相反作用的剪接变体。这种调控调节细胞和组织的稳态,并参与发育和病理过程。此外,最近的证据还揭示了剪接介导的对自噬相关基因的调控,自噬是组织稳态的另一个重要过程。在这篇综述中,我们重点介绍了一些参与细胞存活的最著名的可变剪接事件实例。重点阐述了这种调控在人类癌症和化疗反应中的作用,并举例说明了凋亡基因的可变剪接如何被用于治疗。